SG11201609333YA - A micellar nanocomplex - Google Patents
A micellar nanocomplexInfo
- Publication number
- SG11201609333YA SG11201609333YA SG11201609333YA SG11201609333YA SG11201609333YA SG 11201609333Y A SG11201609333Y A SG 11201609333YA SG 11201609333Y A SG11201609333Y A SG 11201609333YA SG 11201609333Y A SG11201609333Y A SG 11201609333YA SG 11201609333Y A SG11201609333Y A SG 11201609333YA
- Authority
- SG
- Singapore
- Prior art keywords
- micellar nanocomplex
- nanocomplex
- micellar
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6905—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion
- A61K47/6907—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a colloid or an emulsion the form being a microemulsion, nanoemulsion or micelle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/3311—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group
- C08G65/3314—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic
- C08G65/3315—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic aromatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/3311—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group
- C08G65/3314—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic
- C08G65/3315—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic aromatic
- C08G65/3317—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group cyclic aromatic phenolic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/3311—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group
- C08G65/3318—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing a hydroxy group heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3324—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic
- C08G65/3326—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic aromatic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
- C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
- C08G65/3328—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
- C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
- C08G65/32—Polymers modified by chemical after-treatment
- C08G65/329—Polymers modified by chemical after-treatment with organic compounds
- C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
- C08G65/33396—Polymers modified by chemical after-treatment with organic compounds containing nitrogen having oxygen in addition to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/12—Powdering or granulating
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L1/00—Compositions of cellulose, modified cellulose or cellulose derivatives
- C08L1/02—Cellulose; Modified cellulose
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L3/00—Compositions of starch, amylose or amylopectin or of their derivatives or degradation products
- C08L3/02—Starch; Degradation products thereof, e.g. dextrin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/02—Dextran; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/16—Cyclodextrin; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Nanotechnology (AREA)
- Materials Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG11201609333YA SG11201609333YA (en) | 2014-05-09 | 2015-05-08 | A micellar nanocomplex |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201402244S | 2014-05-09 | ||
SG11201609333YA SG11201609333YA (en) | 2014-05-09 | 2015-05-08 | A micellar nanocomplex |
PCT/SG2015/050104 WO2015171079A1 (fr) | 2014-05-09 | 2015-05-08 | Nanocomplexe micellaire |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201609333YA true SG11201609333YA (en) | 2016-12-29 |
Family
ID=54392771
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201609333YA SG11201609333YA (en) | 2014-05-09 | 2015-05-08 | A micellar nanocomplex |
Country Status (18)
Country | Link |
---|---|
US (2) | US10052307B2 (fr) |
EP (1) | EP3139915B1 (fr) |
JP (1) | JP6307631B2 (fr) |
KR (2) | KR20170007780A (fr) |
CN (1) | CN106659708B (fr) |
AU (1) | AU2015256667C1 (fr) |
BR (1) | BR112016026260A2 (fr) |
CA (1) | CA2948460C (fr) |
CU (1) | CU24520B1 (fr) |
EA (1) | EA035820B1 (fr) |
ES (1) | ES2847602T3 (fr) |
IL (1) | IL248632B (fr) |
MX (1) | MX2016014606A (fr) |
SA (1) | SA516380256B1 (fr) |
SG (1) | SG11201609333YA (fr) |
UA (1) | UA118479C2 (fr) |
WO (1) | WO2015171079A1 (fr) |
ZA (1) | ZA201608424B (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6484633B2 (ja) * | 2013-09-03 | 2019-03-13 | エイジェンシー フォー サイエンス,テクノロジー アンド リサーチ | ポリマー−フラボノイド接合体およびバイオメディカル応用のためのヒドロゲル |
MX2016014606A (es) | 2014-05-09 | 2017-08-24 | Agency Science Tech & Res | Un nanocomplejo micelar. |
US9655998B2 (en) | 2014-08-07 | 2017-05-23 | Cook Medical Technologies Llc | Encapsulated drug compositions and methods of use thereof |
US9180226B1 (en) | 2014-08-07 | 2015-11-10 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
US11241520B2 (en) | 2014-08-07 | 2022-02-08 | Cook Medical Technologies Llc | Compositions and devices incorporating water-insoluble therapeutic agents and methods of the use thereof |
CN106511362B (zh) * | 2015-09-15 | 2020-11-17 | 广东省人民医院 | 一种防治动脉粥样硬化的茶多酚组合物 |
KR20170133257A (ko) * | 2016-05-24 | 2017-12-05 | 한양대학교 산학협력단 | 항암제 함유 나노입자를 포함하는 뇌질환 치료를 위한 비강 투여용 약제학적 조성물 |
EP3251662A1 (fr) * | 2016-06-07 | 2017-12-06 | Tolerogenics S.à.r.l. | Adjuvants de tolérance-promotion incorporés à une matrice pour l'immunothérapie sous-cutanée |
WO2018124970A1 (fr) * | 2016-12-30 | 2018-07-05 | Agency For Science, Technology And Research | Nanocomplexe |
KR101810156B1 (ko) * | 2017-02-27 | 2017-12-19 | 인제대학교 산학협력단 | 폴리에틸렌 글리콜 및 플라보노이드 나노복합체를 유효성분으로 함유하는 안구 건조증 예방 또는 치료용 조성물 |
WO2019018774A1 (fr) * | 2017-07-20 | 2019-01-24 | Amri Ssci, Llc | Dispersions amorphes de gallate d'épigallocatéchine |
CN107501584A (zh) * | 2017-08-30 | 2017-12-22 | 天津工业大学 | 一种新型复合膜的制备方法 |
WO2019194543A1 (fr) * | 2018-04-02 | 2019-10-10 | 주식회사 옵티팜 | Microcapsules d'alginate pour l'encapsulation de cellules et leur procédé de fabrication |
EP3806858A4 (fr) | 2018-06-15 | 2022-03-09 | Handa Pharmaceuticals, Inc. | Sels d'inhibiteurs de kinases et compositions associées |
WO2020067730A1 (fr) * | 2018-09-28 | 2020-04-02 | 주식회사 삼양바이오팜 | Composition comprenant de la doxorubicine utilisée comme principe actif et son procédé de préparation |
SG11202105128RA (en) * | 2018-12-12 | 2021-06-29 | Agency Science Tech & Res | Conjugates and nanoparticles of hyaluronic acid and epigallocatechin-3-o-gallate and uses thereof |
CN109820815B (zh) * | 2019-02-15 | 2022-02-08 | 山东师范大学 | 一种具有pH响应的姜黄素胶束水凝胶及其制备方法 |
WO2020252648A1 (fr) * | 2019-06-18 | 2020-12-24 | 四川瀛瑞医药科技有限公司 | Conjugué de pectine-doxorubicine, son procédé de préparation et son application |
WO2021163097A1 (fr) | 2020-02-14 | 2021-08-19 | Chang Gung Memorial Hospital | Peptides ciblant le cancer à répétition en tandem pour conjugaison ou ingénierie moléculaire et leurs utilisations en théranostic du cancer |
US20210283064A1 (en) * | 2020-02-25 | 2021-09-16 | The Chinese University Of Hong Kong | Stable, bioadhesive, and diffusion-restrictive coacervate |
WO2023043367A2 (fr) * | 2021-09-15 | 2023-03-23 | Agency For Science, Technology And Research | Nanocomplexes à base de thé vert pour maladie oculaire |
WO2023076220A1 (fr) * | 2021-10-25 | 2023-05-04 | Board Of Regents, The University Of Texas System | Conjugués comportant des nanoparticules antisalissures et méthodes d'utilisation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000074662A2 (fr) * | 1999-06-07 | 2000-12-14 | University Of Sheffield | Traitement de l'arthrite |
WO2006116532A2 (fr) * | 2005-04-28 | 2006-11-02 | University Of Massachusetts Lowell | Synthese d'oligo/poly(catechines) et methodes d'utilisation associees |
EP1888651B1 (fr) * | 2005-05-20 | 2014-07-30 | Agency for Science, Technology and Research | Preparations de flavonoides conjugues a des aldehydes |
EP2214715B1 (fr) * | 2007-10-23 | 2018-04-18 | Agency For Science, Technology And Research | Procédé d'administration d'un agent anti-cancereux à une cellule |
SG184027A1 (en) * | 2010-03-11 | 2012-10-30 | Agency Science Tech & Res | Anti-cancer agent delivery vehicles capable of improved laoding |
JP2012005413A (ja) * | 2010-06-24 | 2012-01-12 | Osamu Numata | 高分子ポリフェノールを含有する発酵茶抽出物の調製方法 |
EP2771030A4 (fr) * | 2011-10-24 | 2015-07-22 | Intellect Neurosciences Inc | Compositions et méthodes de traitement de protéinopathies |
JP6484633B2 (ja) * | 2013-09-03 | 2019-03-13 | エイジェンシー フォー サイエンス,テクノロジー アンド リサーチ | ポリマー−フラボノイド接合体およびバイオメディカル応用のためのヒドロゲル |
BR112015024589A2 (pt) * | 2014-01-24 | 2017-07-18 | Linde Process Plants Inc | métodos para a separação de gases de hidrocarbonetos |
MX2016014606A (es) | 2014-05-09 | 2017-08-24 | Agency Science Tech & Res | Un nanocomplejo micelar. |
-
2015
- 2015-05-08 MX MX2016014606A patent/MX2016014606A/es unknown
- 2015-05-08 ES ES15789009T patent/ES2847602T3/es active Active
- 2015-05-08 CU CU2016000164A patent/CU24520B1/es unknown
- 2015-05-08 KR KR1020167034578A patent/KR20170007780A/ko active Search and Examination
- 2015-05-08 JP JP2016566958A patent/JP6307631B2/ja active Active
- 2015-05-08 US US15/309,675 patent/US10052307B2/en active Active
- 2015-05-08 EA EA201692213A patent/EA035820B1/ru not_active IP Right Cessation
- 2015-05-08 UA UAA201612494A patent/UA118479C2/uk unknown
- 2015-05-08 CN CN201580035396.6A patent/CN106659708B/zh active Active
- 2015-05-08 BR BR112016026260-3A patent/BR112016026260A2/pt not_active Application Discontinuation
- 2015-05-08 AU AU2015256667A patent/AU2015256667C1/en not_active Ceased
- 2015-05-08 CA CA2948460A patent/CA2948460C/fr active Active
- 2015-05-08 KR KR1020197022703A patent/KR102102093B1/ko active IP Right Grant
- 2015-05-08 EP EP15789009.6A patent/EP3139915B1/fr active Active
- 2015-05-08 WO PCT/SG2015/050104 patent/WO2015171079A1/fr active Application Filing
- 2015-05-08 SG SG11201609333YA patent/SG11201609333YA/en unknown
-
2016
- 2016-10-31 IL IL248632A patent/IL248632B/en active IP Right Grant
- 2016-11-08 SA SA516380256A patent/SA516380256B1/ar unknown
- 2016-12-07 ZA ZA2016/08424A patent/ZA201608424B/en unknown
-
2018
- 2018-07-18 US US16/039,098 patent/US10463646B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ZA201608424B (en) | 2019-12-18 |
JP6307631B2 (ja) | 2018-04-04 |
IL248632B (en) | 2021-03-25 |
EA201692213A1 (ru) | 2017-06-30 |
US10052307B2 (en) | 2018-08-21 |
EP3139915B1 (fr) | 2020-11-04 |
EA035820B1 (ru) | 2020-08-17 |
KR20190095510A (ko) | 2019-08-14 |
SA516380256B1 (ar) | 2021-02-25 |
CN106659708A (zh) | 2017-05-10 |
AU2015256667B2 (en) | 2018-04-19 |
ES2847602T3 (es) | 2021-08-03 |
AU2015256667C1 (en) | 2018-07-05 |
CU20160164A7 (es) | 2017-05-10 |
BR112016026260A2 (pt) | 2021-08-03 |
EP3139915A1 (fr) | 2017-03-15 |
AU2015256667A1 (en) | 2016-11-17 |
KR102102093B1 (ko) | 2020-04-17 |
US10463646B2 (en) | 2019-11-05 |
CA2948460C (fr) | 2020-10-13 |
MX2016014606A (es) | 2017-08-24 |
WO2015171079A1 (fr) | 2015-11-12 |
JP2017518280A (ja) | 2017-07-06 |
CU24520B1 (es) | 2021-06-08 |
UA118479C2 (uk) | 2019-01-25 |
CA2948460A1 (fr) | 2015-11-12 |
US20170258926A1 (en) | 2017-09-14 |
US20190008830A1 (en) | 2019-01-10 |
CN106659708B (zh) | 2022-05-10 |
KR20170007780A (ko) | 2017-01-20 |
EP3139915A4 (fr) | 2017-12-20 |
IL248632A0 (en) | 2017-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL276199B (en) | The composition containing gemcitabine-meter drug | |
ZA201608424B (en) | A micellar nanocomplex | |
HK1214981A1 (zh) | 微型加濕器 | |
PT3107946T (pt) | Poliiso-ureia | |
HK1244767A1 (zh) | 液體分裝器 | |
GB201416345D0 (en) | A pack | |
GB2517601B (en) | A plinth | |
GB201402247D0 (en) | A footgauge | |
GB201409666D0 (en) | A bat | |
HK1255066A1 (zh) | 條形音箱 | |
GB201511682D0 (en) | A case | |
GB201411365D0 (en) | A barbecue | |
HUE046322T2 (hu) | Mikoherbicid | |
GB201415162D0 (en) | A Case | |
GB201416247D0 (en) | A formulation | |
GB201404865D0 (en) | A Hydrogenerator | |
GB201411974D0 (en) | A case | |
GB201400958D0 (en) | n/a | |
GB201411681D0 (en) | Concept a | |
GB201400532D0 (en) | Metix limited COREMED A | |
ZA201500160B (en) | A mid-hinge mast | |
GB201419012D0 (en) | A composition | |
GB201414050D0 (en) | A composition | |
GB201419832D0 (en) | A putting aid | |
GB201419224D0 (en) | A pump |